October 7, 2022
Checkpoint Surgical, Inc., a privately held U.S.-based medical device company with proprietary neurostimulation technology for nerve protection and repair, raised $16 million of growth capital in August of 2021. One year later, with those investments in place, the company is shifting into growth mode, a move that comes with substantial changes. Executive Advisor Len Cosentino talks about the raise, his process for vetting investors and how Checkpoint is setting itself up for profitability.
April 22, 2022
The recently launched Palo Alto-based OVO Fund III has closed after reaching its goal of $50 million. And it achieved that mark with help from an Ohio syndicate of investors whose combined $8 million for OVO Fund III makes them one of the more substantial investors in the Silicon Valley-based OVO Fund.
April 8, 2022
Within3's Lance Hill, along with Huntington Bank's Jamie Lynch and John Langenderfer, University Hospitals Health System's Eric Beck, and ValueHealth's John Palumbo explore how health care entrepreneurs fuel growth.
February 11, 2022
Play One Up CEO Brandon Pitts talks about the growing esports industry, building Play One Up and how he pitches investors who might not be familiar with the opportunity.
December 16, 2021
Daniel Walsh talks about launching Citymark Capital, building funds, creating value and the special place Austin holds in the company’s plans.
December 17, 2020
Greg Skoda, speaking at the Smart Business Dealmakers Conference in September, offered his take on companies’ pandemic capital situation, and how business owners and executives have responded.
June 28, 2019
When you’re an investor being asked to provide millions of dollars in capital to a growing business, you want a lot of details about how that money will be used.“I would bet 90 percent of the
May 15, 2019
Recapitalization — the process of changing a company’s capital structure through the issuance of new debt or equity securities — is a popular way to fund acquisitions, growth strategies, partner
April 30, 2019
The serial entrepreneur and CEO of SPR Therapeutics talks about her process for raising capital, as well as the role non-dilutive capital has played in her fundraising formula.
April 16, 2019
XaTek CEO John Zak shares his approach to raising capital and the advantage of doing it all at once.